65,437 trials
Orthodontic Patient Experience
Primary: Orthodontic Patient Comfort — 9.2; 7.7 score on a scale — p=0.0006
Dermatitis
Primary: Number of Participants Who Responded to Treatment With IGA Scale — 3 Participants
Tobacco Use Disorder
Primary: Number of Cigarettes Smoked Per Day — 22.54; 14.32; 11.76; 7.63 cigarettes per day
Dry Eye Disease
Primary: University of North Carolina Dry Eye Management Scale (UNC DEMS) Responder Analysis — 65.4; 90.0; 66.0; 71.4 percentage of responders — p=0.0040
Diffuse Lewy Body Disease · Dementia With Lewy Bodies · Parkinson's Disease Dementia
Primary: Absolute 11C-PBR28 Binding (Total Distribution Volume Corrected for Free Fraction in Plasma) — 0.15 kBq·cm-3 / kBq·mL-1
Burnout, Caregiver · Burnout, Professional · COVID-19
Primary: Montgomery-Asberg Depression Rating Scale — 21.33; 9.33 score on a scale — p=<.001
Diabetes Mellitus · Obesity
Primary: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) (Safety and Tolerability) — 2; 1; 1; 3 Participants
C. Diff. Infections
Primary: Number of Participants With Presence of Capsules and/or Transit Markers in Ostomy Fluid by Visual Observation — 0; 0; 0; 0 Participants
Carcinoma In Situ · Current Smoker · Malignant Neoplasm
Primary: Biochemically-confirmed 7-day Point Prevalence Abstinence at 6 Months (Not Evaluated)
Neonatal Critical Illness · Pediatric Critical Illness
Primary: Enrollment Rate (Critically Ill Infants) — 24; 30 Participants
Urinary Retention
Primary: Residual Urine at 1st Flow Stop (HCP-led Catheterization) i.e., Total Catheterisation Volume Minus Volume at 1st Flow-stop, Both Derived From a Catheterisation Profile…
Diabetes Mellitus, Type 2
Primary: Change (From Baseline) in Self-reported Intake (Servings/Day) of Sugar-sweetened Beverages (Measured Using the Nutrition Assessment Shared Resource Food Frequency…
Musculoskeletal Pain · Pain, Chronic
Primary: Short Physical Performance Battery (SPPB) — 10.95; 10.82; 11.75 score on a scale — p=0.0561
Hypertriglyceridemia · Pediatric Obesity
Primary: Percentage Change in Serum Triglyceride Levels From Baseline to Week 12 of Study Treatment — -39.1; -14.6 Percent change (%) — p=<0.01
Obesity
Primary: Participant Satisfaction With the Intervention — 2; 1; 0; 0 Participants